Jon P. Stonehouse Sells 61,793 Shares of Common Stock in BIOCRYST PHARMACEUTICALS INC

Jon P. Stonehouse, Chief Executive Officer and Director of BIOCRYST PHARMACEUTICALS INC, reported a disposition of 61,793 shares of Common Stock on December 19, 2025. The shares were sold at a price of $7.41 per share. This transaction resulted in a post-transaction share count of 1,323,429. The filing also details indirect holdings, including 40,000 shares held by his wife as co-trustee of the Caroline Stonehouse Irrevocable Trust and 40,000 shares held by his wife as co-trustee of the Samuel Stonehouse Irrevocable Trust. A footnote indicates that the shares were withheld by the Issuer to satisfy tax obligations related to the vesting of restricted stock units and do not represent an actual sale by the reporting person.